Prediction of DNA damage and G2 chromosomal radio-sensitivity ex vivo in peripheral blood mononuclear cells with label-free Raman micro-spectroscopy

Abstract Purpose: Liquid biopsies are a potentially rich store of biochemical information that can be linked to an individual’s response to therapeutic treatments, including radiotherapy, and which may ultimately play a role in the individualization of treatment regimens. Peripheral blood mononuclear cells (PBMCs) can be used not only for the biochemical profiling of the individual, but also, being living cells, can provide insights into the individuals response to ionizing radiation exposure. Materials and methods: The present study attempts to link the biochemical profile of lymphocytes within PBMCs obtained through Raman spectroscopy to in vitro measures of low-dose (<0.5Gy) DNA damage response and cytogenetic metrics of radiosensitivity in a cohort of healthy controls and prostate cancer patients (from CTRIAL-IE(ICORG) 08-17, NCT00951535). All parallel metrics to the Raman spectra of the cells were obtained ex vivo in cycling peripheral blood lymphocytes, with radiosensitivity estimated using the G2 chromosomal assay and DNA damage assessed using γH2AX fluorescence. Spectra from a total of 26 healthy volunteers and 22 prostate cancer patients were obtained. Results: The links between both measures of cellular response to ionizing radiation and the Raman spectra were modeled using partial least squares regression (PLSR) and support-vector regression (SVR). It was found that neither regression approach could predict radiation-induced G2 score well, but could predict γH2AX MFI with the SVR outperforming PLSR, implying a non-linear relationship between spectral measurements and measures of DNA damage. Conclusions: Raman spectroscopy of PBMCs represents a label-free approach for prediction of DNA damage levels for either prospective or retrospective analysis.

[1]  H. Thierens,et al.  Chromosomal aberrations and in vitro radiosensitivity: intra-individual versus inter-individual variability. , 2004, Toxicology letters.

[2]  C. West,et al.  Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? , 2016, Cancer letters.

[3]  Peter Knief,et al.  Growth substrate induced functional changes elucidated by FTIR and Raman spectroscopy in in–vitro cultured human keratinocytes , 2007, Analytical and bioanalytical chemistry.

[4]  S. Elledge,et al.  The DNA damage response: putting checkpoints in perspective , 2000, Nature.

[5]  Bernhard Schölkopf,et al.  A tutorial on support vector regression , 2004, Stat. Comput..

[6]  S. Roberts,et al.  Chromosomal radiosensitivity as a marker of predisposition to common cancers? , 2001, British Journal of Cancer.

[7]  Giatromanolaki Alexandra,et al.  Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay. , 2010, International journal of radiation oncology, biology, physics.

[8]  S. Roberts,et al.  Less G2 arrest in irradiated cells of breast cancer patients than in female controls: a contribution to their enhanced chromosomal radiosensitivity? , 2003, International journal of radiation biology.

[9]  C. Kendall,et al.  Raman spectroscopy for medical diagnostics--From in-vitro biofluid assays to in-vivo cancer detection. , 2015, Advanced drug delivery reviews.

[10]  William F. Blakely,et al.  The Use of Gamma-H2AX as a Biodosimeter for Total-Body Radiation Exposure in Non-Human Primates , 2010, PloS one.

[11]  D. Evans,et al.  Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? , 1999, American journal of human genetics.

[12]  Ganesh D Sockalingum,et al.  Vibrational spectroscopy in sensing radiobiological effects: analyses of targeted and non-targeted effects in human keratinocytes. , 2016, Faraday discussions.

[13]  A. Vral,et al.  Technical report. The G2 chromosomal radiosensitivity assay , 2002, International journal of radiation biology.

[14]  A D Meade,et al.  Fourier Transform Infrared Microspectroscopy and Multivariate Methods for Radiobiological Dosimetry , 2010, Radiation research.

[15]  H. Andersson,et al.  Chromosomal sensitivity to X-ray irradiation during the G2 phase in lymphocytes of patients with hereditary cutaneous malignant melanoma as compared to healthy controls. , 1999, Mutation research.

[16]  R. Parshad,et al.  Cytogenetic responses to G2 phase x-irradiation of cells from retinoblastoma patients. , 1996, Cancer genetics and cytogenetics.

[17]  H. Byrne,et al.  Raman spectroscopy for cytopathology of exfoliated cervical cells. , 2016, Faraday discussions.

[18]  Ruth C Wilkins,et al.  The response of gamma-H2AX in human lymphocytes and lymphocytes subsets measured in whole blood cultures , 2009, International journal of radiation biology.

[19]  R. Parshad,et al.  Factors affecting and significance of G2 chromatin radiosensitivity in predisposition to cancer. , 1989, International journal of radiation biology.

[20]  C. Mothersill,et al.  Cell Death Mechanisms Associated with G2 Radiosensitivity in Patients with Prostate Cancer and Benign Prostatic Hyperplasia , 2005, Radiation research.

[21]  David J. Chen,et al.  Cellular responses to DNA double-strand breaks after low-dose γ-irradiation , 2009, Nucleic acids research.

[22]  Bernhard Schölkopf,et al.  New Support Vector Algorithms , 2000, Neural Computation.

[23]  Nello Cristianini,et al.  An introduction to Support Vector Machines , 2000 .

[24]  A Maguire,et al.  Analyses of Ionizing Radiation Effects In Vitro in Peripheral Blood Lymphocytes with Raman Spectroscopy , 2015, Radiation research.

[25]  F. Lyng,et al.  Development of a high throughput (HT) Raman spectroscopy method for rapid screening of liquid blood plasma from prostate cancer patients. , 2017, The Analyst.

[26]  A. Micke,et al.  Multichannel film dosimetry with nonuniformity correction. , 2011, Medical physics.

[27]  K. Rothkamm,et al.  Combined Analysis of Gamma-H2AX/53BP1 Foci and Caspase Activation in Lymphocyte Subsets Detects Recent and More Remote Radiation Exposures , 2013, Radiation research.

[28]  R. Bristow,et al.  Erratum: Late residual c-H2AX foci in murine skin are dose responsive and predict radiosensitivity (Radiation Research (2010) 172 (1-9)) , 2010 .

[29]  Q Matthews,et al.  Raman spectroscopy of single human tumour cells exposed to ionizing radiation in vitro , 2011, Physics in medicine and biology.

[30]  R. Bristow,et al.  Late Residual γ-H2AX Foci In Murine Skin are Dose Responsive and Predict Radiosensitivity In Vivo , 2010, Radiation research.

[31]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[32]  Peter Filzmoser,et al.  Introduction to Multivariate Statistical Analysis in Chemometrics , 2009 .

[33]  C. Mothersill,et al.  Elevated G2 chromosomal radiosensitivity in Irish breast cancer patients: a comparison with other studies , 2005, International journal of radiation biology.

[34]  Maria F Chan,et al.  An efficient protocol for radiochromic film dosimetry combining calibration and measurement in a single scan. , 2012, Medical physics.

[35]  S. Roberts,et al.  Radiation-induced G2 Delay and Spontaneous Chromosome Aberrations in Ataxia-telangiectasia Homozygotes and Heterozygotes. , 1994, International Journal of Radiation Biology.

[36]  R. Parshad,et al.  Chromatid damage after G2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Nello Cristianini,et al.  An Introduction to Support Vector Machines and Other Kernel-based Learning Methods , 2000 .

[38]  L. Thompson.  Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. , 2012, Mutation research.

[39]  Pascale Voisin,et al.  Quantification of γ-H2AX Foci in Human Lymphocytes: A Method for Biological Dosimetry after Ionizing Radiation Exposure , 2010, Radiation research.

[40]  C. Redon,et al.  γ-H2AX and other histone post-translational modifications in the clinic. , 2012, Biochimica et biophysica acta.

[41]  C. Kendall,et al.  Towards the intra-operative use of Raman spectroscopy in breast cancer—overcoming the effects of theatre lighting , 2016, Lasers in Medical Science.

[42]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[43]  Kai Rothkamm,et al.  Gamma-H2AX-Based Dose Estimation for Whole and Partial Body Radiation Exposure , 2011, PloS one.

[44]  R. Moses.  DNA damage processing defects and disease. , 2001, Annual review of genomics and human genetics.

[45]  Andre Dekker,et al.  Radiogenomics: radiobiology enters the era of big data and team science. , 2014, International journal of radiation oncology, biology, physics.

[46]  E. Gabrielson,et al.  Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. , 2002, The American journal of pathology.

[47]  Hugh J. Byrne,et al.  Selection of preprocessing methodology for multivariate regression of cellular FTIR and Raman spectra in radiobiological analyses , 2014, 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[48]  S. Roberts,et al.  Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients , 2001, British Journal of Cancer.

[49]  C. Coles,et al.  Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part I--normal tissue complications. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

[50]  C. Coles,et al.  Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part II--Radiotherapy strategies to reduce radiation-induced late effects. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

[51]  H. Eich,et al.  Evaluation of Different Biomarkers to Predict Individual Radiosensitivity in an Inter-Laboratory Comparison–Lessons for Future Studies , 2012, PloS one.

[52]  H. Barr,et al.  Advances in the clinical application of Raman spectroscopy for cancer diagnostics. , 2013, Photodiagnosis and photodynamic therapy.

[53]  S C Lillicrap,et al.  Code of Practice for high-energy photon therapy dosimetry based on the NPL absorbed dose calibration service , 1990 .

[54]  R. Parshad,et al.  Deficient DNA repair capacity, a predisposing factor in breast cancer. , 1996, British Journal of Cancer.

[55]  Elisa Calamia,et al.  Clinical use of EBT model Gafchromic film in radiotherapy. , 2006, Medical physics.

[56]  A. Thompson,et al.  Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics , 2001, British Journal of Cancer.